(Q42150425)

17 October 2017

1 reference

title

Thymoma in myasthenia gravis: from diagnosis to treatment (English)

1 reference

17 October 2017

0 references

Fredrik Romi

1

1 reference

17 October 2017

10 August 2011

1 reference

17 October 2017

1 reference

17 October 2017

2011

1 reference

17 October 2017

474512

1 reference

Creative Commons Attribution 3.0 Unported

17 October 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The biologic spectrum of thymic epithelial neoplasms: current status and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Detection of multiple antibodies in myasthenia gravis and its clinical significance

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Video-assisted thoracoscopic surgery or transsternal thymectomy in the treatment of myasthenia gravis?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Thymoma and paraneoplastic myasthenia gravis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Immunosuppressive therapies in myasthenia gravis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Structure-function relations of the giant elastic protein titin in striated and smooth muscle cells

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Advances in the diagnosis of neuromuscular junction disorders

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Myasthenia gravis: clinical, immunological, and therapeutic advances

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Paraneoplastic neurological degenerations: keys to tumour immunity

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Treatment of autoimmune myasthenia gravis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Intravenous immunoglobulin for myasthenia gravis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Plasma exchange for myasthenia gravis.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Muscle autoantibodies in subgroups of myasthenia gravis patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Acetylcholine receptors and myasthenia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Pathological aspects of malignant and benign thymic disorders.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

The pathological basis of thymoma-associated myasthenia gravis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Clinical and immunological differences between early and late-onset myasthenia gravis in Japan.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Polygenic disease associations in thymomatous myasthenia gravis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Morphological effects of myasthenia gravis patient sera on human muscle cells

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Clinical study of fk506 in patients with myasthenia gravis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3155972

A CTLA4high genotype is associated with myasthenia gravis in thymoma patients

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.4061%2F2011%2F474512

Long-term prognostic analysis of thymectomized patients with myasthenia gravis

21 January 2018

1 reference

12 December 2020

Selective loss of regulatory T cells in thymomas

1 reference

12 December 2020

Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies

1 reference

12 December 2020

Thymectomy for myasthenia gravis: a 27-year experience

1 reference

12 December 2020

Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features

1 reference

12 December 2020

Titin Antibodies in Patients with Late Onset Myasthenia Gravis: Clinical Correlations

1 reference

12 December 2020

Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients

1 reference

12 December 2020

Late-onset myasthenia gravis: a changing scene

1 reference

12 December 2020

Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis

1 reference

12 December 2020

Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin

1 reference

12 December 2020

Cell-mediated immune response against titin in myasthenia gravis: evidence for the involvement of Th1 and Th2 cells

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/474512

1 reference

17 October 2017

1 reference

17 October 2017

1 reference

PMCID

3155972